Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

CPR > First Aid Pharmacology > Flashcards

First Aid Pharmacology Flashcards

1
Q

Nifedipine

A
  • Dihydropyridine Calcium channel blocker
  • Blocks volt-dependent Ca2+ channels of cardiac & smooth m.
  • Reduces muscle contractility
  • Of CCBs nifedipine has most action of vessels and least on heart
  • Use: HTN, angina, Prinzemetal angina, Raynaud’s
  • Toxicity: Cardiac depression, AV block, edema, flushing, dizzy, constipation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Nitroprusside

A
  • Short acting
  • Increase cGMP via direct release of NO
  • Used for Malignant HTN
  • Tox: can cause cyanide toxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Fenoldapam

A
  • Dopamine D1 receptor agonist
  • Relaxes renal vascular smooth muscle
  • Used for Malignant HTN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Diazoxide

A
  • K+ channel opener
  • Hyperpolarizes and relaxes vascular smooth muscle
  • Used for malignant HTN
  • Tox: hyperglycemia by reducing insulin release
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Verapamil

A
  • Non-dyhidropyradine Calcium channel blocker
  • Blocks volt-dependent Ca2+ channels of cardiac & smooth m.
  • Reduces muscle contractility
  • Of CCBs Verapamil has most action on heart and least on vessel
  • Use: Arrhythmias, HTN, angina, Prinzemetal angina, Raynaud’s
  • Toxicity: Cardiac depression, AV block, edema, flushing, dizzy, constipation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Diltiazem

A
  • Non-dyhidropyradine Calcium channel blocker
  • Blocks volt-dependent Ca2+ channels of cardiac & smooth m.
  • Reduces muscle contractility
  • Of CCBs Diltiazem has equal action on heart and vessel
  • Use: Arrhythmias, HTN, angina, Prinzemetal angina, Raynaud’s
  • Toxicity: Cardiac depression, AV block, edema, flushing, dizzy, constipation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Amlodipine

A
  • Long acting Dihydropyradine Ca2+ channel blocker
  • Blocks volt-dependent Ca2+ channels of cardiac & smooth m.
  • Reduces muscle contractility
  • Of CCBs Verapamil has most action on heart and least on vessel
  • Use: Arrhythmias, HTN, angina, Prinzemetal angina, Raynaud’s
  • Toxicity: Cardiac depression, AV block, edema, flushing, dizzy, constipation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Nitroglycerine

A
  • Vasodilate by releasing NO in smooth muscle
  • Increases cGMP-> smooth muscle relaxation
  • Dilates veins»arteries: decrease preload
  • Use: Angina, pulmonary edema, ED
  • TOX: reflex tachycardia, flushing, headache, tolerance for vasodilating action during workweek and loss over weekend resulting in tachycardia, dizziness, and headache on re-exposure in industrial setting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Isosorbide

A
  • Vasodilate by releasing NO in smooth muscle
  • Increases cGMP-> smooth muscle relaxation
  • Dilates veins»arteries: decrease preload
  • Use: Angina, pulmonary edema, ED
  • TOX: reflex tachycardia, flushing, headache, tolerance for vasodilating action during workweek and loss over weekend resulting in tachycardia, dizziness, and headache on re-exposure in industrial setting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Dinitrate

A
  • Vasodilate by releasing NO in smooth muscle
  • Increases cGMP-> smooth muscle relaxation
  • Dilates veins»arteries: decrease preload
  • Use: Angina, pulmonary edema, ED
  • TOX: reflex tachycardia, flushing, headache, tolerance for vasodilating action during workweek and loss over weekend resulting in tachycardia, dizziness, and headache on re-exposure in industrial setting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Statins: Lovastatin, pravastatin, simvastatin, etc

A
  • HMG-CoA Reductase inhibitors
  • Inhibits cholesterol precursor, mevalonate
  • Huge decrease in LDL
  • Mild increase in HDL
  • Mild decrease in TG
  • TOX: hepatotoxicity, rhabdo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Niacin

A
  • direct decrease in hepatic synthesis of VLDL
  • Inhibits lipolysis in fat
  • Decreases LDL
  • Increases HDL
  • Slight decrease TG
  • TOX: red, flush, hyperglycemia, hyperuricemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cholestyramine

A
  • Bile acid resins
  • binds bile acids in the intestinal lumen; inhibits the reabsorption of bile acid.
  • cholesterol is the precursor of bile acid
  • Inhibition of bile reabsorption causes increased channeling of cholesterol to the production of bile acids
  • Decreases LDL
  • Slightly increases HDL
  • Slightly increases TG
  • Tox: patients hate it…bad taste, GI upset, Decreased absorption of fat soluble vitamins, cholesterol gallstones
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Colestipol

A
  • Bile acid resins
  • binds bile acids in the intestinal lumen; inhibits the reabsorption of bile acid.
  • cholesterol is the precursor of bile acid
  • Inhibition of bile reabsorption causes increased channeling of cholesterol to the production of bile acids
  • Decreases LDL
  • Slightly increases HDL
  • Slightly increases TG
  • Tox: patients hate it…bad taste, GI upset, Decreased absorption of fat soluble vitamins, cholesterol gallstones
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Colesvelam

A
  • Bile acid resins
  • binds bile acids in the intestinal lumen; inhibits the reabsorption of bile acid.
  • cholesterol is the precursor of bile acid
  • Inhibition of bile reabsorption causes increased channeling of cholesterol to the production of bile acids
  • Decreases LDL
  • Slightly increases HDL
  • Slightly increases TG
  • Tox: patients hate it…bad taste, GI upset, Decreased absorption of fat soluble vitamins, cholesterol gallstones
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ezetimibe

A
  • works on the brush border of the gut wall to prevent cholesterol absorption through the intestinal villi
  • Decreases LDL
  • No effect on HDL or TG
  • Rare increase on liver function test
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Gemfibrozil

A
  • binds to PPARα (peroxisome proliferator activated receptor α) in liver & brown fat.
  • PPARα activation regulates gene transcription resulting in:
    1. increased lipoprotein lipase activity -VLDL & TG catabolism
    2. decreased VLDL synthesis and excretion by liver
    3. increased HDL cholesterol (due to increased synthesis of apoA-I and apoA-II)
  • Decrease LDL, Increase HDL
  • HUGE decrease in TG
  • TOX: Myositis, hepatotoxicity, cholesterol gallstones
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Fenofibrate

A
  • binds to PPARα (peroxisome proliferator activated receptor α) in liver & brown fat.
  • PPARα activation regulates gene transcription resulting in:
    1. increased lipoprotein lipase activity -VLDL & TG catabolism
    2. decreased VLDL synthesis and excretion by liver
    3. increased HDL cholesterol (due to increased synthesis of apoA-I and apoA-II)
  • Decrease LDL, Increase HDL
  • HUGE decrease in TG
  • TOX: Myositis, hepatotoxicity, cholesterol gallstones
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Digoxin

A

-Cardiac Glycosides
-Direct inhibition of Na/K ATPase-> Indirect inhibition of Na/Ca exchanger
-Increases [Ca]i
-Positive inotropy (Contractility)
-Stimulates vagus nerve
-Use: CHF (increased contractility), Afib (decreased conduction at AVN and depression of SAN
-TOX: N/V/D blurry vision, Increased PR, Decreased QT, swooping T wave inversion, arrhythmia, hyperkalemia
*Worsened by renal failure: decreased excretion
*Hypokalemia: allow dig binding on Na/K ATPase
*Quinidine: decreased clearence
Antidote: Normalize K+, lidocaine, pacer, anti-dig Fab fragment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Quinidine

A
  • Class 1a Na+ channel blocker
  • Antiarrhythmetic
  • Increased AP duration
  • Increased effective refractory period
  • Increased QT interval
  • Affect both atrial and ventricular arrhythmias
    • especially reentrant and ectopic SVTs and VT
  • Tox: cinchonism- headache and tinnitus, thrombocytopenia, torsades de pointes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Procainamide

A
  • Class 1a Na+ channel blocker
  • Antiarrhythmetic
  • Increased AP duration
  • Increased effective refractory period
  • Increased QT interval
  • Affect both atrial and ventricular arrhythmias
    • especially reentrant and ectopic SVTs and VT
  • Tox: Reversible SLE like symptoms, thrombocytopenia, torsades de pointes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Disopyramide

A
  • Class 1a Na+ channel blocker
  • Antiarrhythmetic
  • Increased AP duration
  • Increased effective refractory period
  • Increased QT interval
  • Affect both atrial and ventricular arrhythmias
    • especially reentrant and ectopic SVTs and VT
  • Tox: , thrombocytopenia, torsades de pointes
22
Q

Lidocaine

A
  • Class 1b Na+ channel blocker
  • Anti arrhythmic
  • Decreased AP duration
  • Preferentially affects ischemic or depolarized purkinje and ventricular tissue
  • Useful in acute ventricular arrhythmias (post-MI) and digoxin-induced arrhythmias
  • TOX: local anesthetic, CNS stim/depression, CV depression
23
Q

Mexiletine

A
  • Class 1b Na+ channel blocker
  • Anti arrhythmic
  • Decreased AP duration
  • Preferentially affects ischemic or depolarized purkinje and ventricular tissue
  • Useful in acute ventricular arrhythmias (post-MI) and digoxin-induced arrhythmias
  • TOX: local anesthetic, CNS stim/depression, CV depression
24
Tocainide
- Class 1b Na+ channel blocker - Anti arrhythmic - Decreased AP duration - Preferentially affects ischemic or depolarized purkinje and ventricular tissue - Useful in acute ventricular arrhythmias (post-MI) and digoxin-induced arrhythmias - TOX: local anesthetic, CNS stim/depression, CV depression
25
Flecainide
- Class 1c Na+ channel blocker - Antiarrhythmic - No effect on AP duration - Useful in VT that progresses to VF, and in intractable SVT - Used only as last resort in refractory tachyarrhytmias - For pts w/o structural abnormalities - TOX: Contraindicated post-MI b/c proarrhythmic, prolongs refractory period in AVN * Hyperkalemia increases toxicity in all class 1 drugs
26
Propafenone
- Class 1c Na+ channel blocker - Antiarrhythmic - No effect on AP duration - Useful in VT that progresses to VF, and in intractable SVT - Used only as last resort in refractory tachyarrhytmias - For pts w/o structural abnormalities - TOX: Contraindicated post-MI b/c proarrhythmic, prolongs refractory period in AVN * Hyperkalemia increases toxicity in all class 1 drugs
27
Beta blockers "-olols"
- Class II antiarrythmics - Decreases cAMP - decrease Ca2+ currents - Suppressing abnormal pacemakers by decreasing phase 4 slope - AVN most sensitive - Use: VT, SVT, slowing ventricular rate during Afib/flutter - Tox: impotence, asthma, bradycardia, AV block, CHF
28
Ibutilide
- Class III Antiarrhythmics: K+ channel blocker - Increase AP duration - Increase effective refractory period - Increased QT interval - Used with other antiarrhythmic fail - Tox: torsades de pointes
29
Sotalol
- Class III Antiarrhythmics: K+ channel blocker - Increase AP duration - Increase effective refractory period - Increased QT interval - Used with other antiarrhythmic fail - Tox: torsades de pointes, excessive beta block
30
Bretylium
- Class III Antiarrhythmics: K+ channel blocker - Increase AP duration - Increase effective refractory period - Increased QT interval - Used with other antiarrhythmic fail - Tox: new arrhythmias, hypotension
31
Amiodarone
- Class III Antiarrhythmics: K+ channel blocker - Increase AP duration - Increase effective refractory period - Increased QT interval - Used with other antiarrhythmic fail - Tox: pulmonary fibrosis, hepatotoxicity, thyroid problems, corneal and skin deposits, neurologic effects, constipation, bradycardia, heart block, CHF
32
Dofetilide
- Class III Antiarrhythmics: K+ channel blocker - Increase AP duration - Increase effective refractory period - Increased QT interval - Used with other antiarrhythmic fail - Tox: torsades de pointes
33
Adenosine
- Antiarrhythmic - Increases K+ out of cells: hyperpolarizing cell - Decreases Ca2+ current - Drug of choice for SVT - Very short acting - TOX: flush, hypotension, chest pain * Blocked by thephylline
34
Captopril
- Inhibits ACE - Reduces levels of Angiotensin II (vasoconstrictor) - prevents inactivation of bradykinin (vasodilator) - Renin release increase b/c loss of feedback inhibition - Use: HTN, CHF, diabetic renal disease, prevents heart remodeling as result of chronic HTN - TOX: cough, angioedema, proteinuria, taste change, hypotension, fetal renal damage, rash, increased renin, decrease angiotension II, hyperkalemia * Avoid w/ bilateral renal artery stenosis
35
Enalapril
- Inhibits ACE - Reduces levels of Angiotensin II (vasoconstrictor) - prevents inactivation of bradykinin (vasodilator) - Renin release increase b/c loss of feedback inhibition - Use: HTN, CHF, diabetic renal disease, prevents heart remodeling as result of chronic HTN - TOX: cough, angioedema, proteinuria, taste change, hypotension, fetal renal damage, rash, increased renin, decrease angiotension II, hyperkalemia * Avoid w/ bilateral renal artery stenosis
36
Lisinopril
- Inhibits ACE - Reduces levels of Angiotensin II (vasoconstrictor) - prevents inactivation of bradykinin (vasodilator) - Renin release increase b/c loss of feedback inhibition - Use: HTN, CHF, diabetic renal disease, prevents heart remodeling as result of chronic HTN - TOX: cough, angioedema, proteinuria, taste change, hypotension, fetal renal damage, rash, increased renin, decrease angiotension II, hyperkalemia * Avoid w/ bilateral renal artery stenosis
37
Spironolactone
- K+sparing diuretic - Competitive aldosterone receptor antagonist * Blocks Na retention & K excretion - Use: HTN and CHF - TOX: hyperkalemia
38
Eplerenone
- K+sparing diuretic - Competitive aldosterone receptor antagonist * Blocks Na retention & K excretion - Use: HTN and CHF - TOX: hyperkalemia
39
Losartan
- AT1 receptor blocker - Interferes w/ binding of Angiotensin II to receptor (no effect on bradykinin) - Use: HTN (less effective in blacks) , CHF
40
Aliskiren
-Renin inhibitor
41
Heparin
- Cofactor for the activation of antithrombin - Decreases thrombin and Factor Xa - Short half life - Use: anticoagulation for PE, stroke, acute coronary syndrome, MI, DVT, and can be used during pregnancy - TOX: bleeding, HIT, osteoporosis, interactions * antidote: protamine sulfate binds - charged heparin
42
Enoxaprin
- Low Molecular Weight Heparin - acts more on Xa - Better availability and longer half life - Can be administered subQ w/o labs - Used for the same stuff as heparin
43
Lepirudin
- Hirudin derivative (from leeches) - directly inhibits thrombin - Used as alternate to heparin in patients w/ HIT
44
Bivalirudin
- Hirudin derivative (from leeches) - directly inhibits thrombin - Used as alternate to heparin in patients w/ HIT
45
Warfarin
- Interferes w/ normal synth and gamma carboxylation of Vit. K dependent clotting factors (II, VII, IX, X, protein C and S) - Metabolized by p450s - Effects extrinsic pathway - Increases PT - Use: chronic anticoagulation (post STEMI, venous thromboembolism) - Can't use if pregnant (crosses placenta) - TOX: bleeding, teratogenic, interactions
46
Streptokinase
- Thrombolytic - Indirectly aids conversion of plasminogen to plasmin - Plasmin cleaves thrombin and fibrin clots - Increased PT and PTT, no change in platelet count - Use: MI, early ischemic stroke - TOX: bleeding, HTN, (don't use w/ active bleeding, hx of intracranial bleeds, recent surgery) * Treat tox w/ aminocaprotic acid that inhibits fibrinolysis
47
tPA
- Thrombolytic - Indirectly aids conversion of plasminogen to plasmin - Plasmin cleaves thrombin and fibrin clots - Increased PT and PTT, no change in platelet count - Use: MI, early ischemic stroke - TOX: bleeding, HTN, (don't use w/ active bleeding, hx of intracranial bleeds, recent surgery) * Treat tox w/ aminocaprotic acid that inhibits fibrinolysis
48
Aspirin
- Acetylates and irreversibly inhibits COX1 and COX2 - Prevents conversion of Arachidonic acid to thromboxane A2 - Increases bleeding time - No effect on PT or PTT - Use: antipyretic, analgesic, anti-inflammatory, antiplatelet drug - TOX: gastric ulceration, bleeding, hyperventilation, Reye's syndrome in kids
49
Clopidogrel
- Inhibits platelet aggregation - Irreversibly blocks ADP receptors - Inhibits fibrinogen binding by preventing GP IIb/IIIa expression - Use: acute coronary syndrome, coronary stenting
50
Ticlopidine
- Inhibits platelet aggregation - Irreversibly blocks ADP receptors - Inhibits fibrinogen binding by preventing GP IIb/IIIa expression - Use: acute coronary syndrome, coronary stenting - TOX: neutropenia
51
Cilostazol
- PDE III inhibitor - Increases cAMP in platelets * inhibits platelet aggregation - Vasodilator - Use: intermittant claudication, coronary vasodilation, prevent stroke/TIA, angina prophylaxis - TOX: nausea, headache, flushing, hypotension, abdominal pain
52
Dipyridamole
- PDE III inhibitor - Increases cAMP in platelets * inhibits platelet aggregation - Vasodilator - Use: intermittant claudication, coronary vasodilation, prevent stroke/TIA, angina prophylaxis - TOX: nausea, headache, flushing, hypotension, abdominal pain
53
Abciximab
- Monoclonal antibody that binds GP IIb/IIIa on activated platelets - Prevents platelet aggregation - Use: acute coronary syndrome, coronary angioplasty - TOX: bleeding, thrombocytopenia

CPR (13 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions